Shreeoswal Seeds & Chemicals Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 18, 2025, 10:21 am

Quick Insight

Shreeoswal Seeds & Chemicals Ltd, with a market capitalization of 135 Cr. and a P/E ratio of 9.99, presents an interesting investment opportunity in the seeds/tissue culture/biotechnology industry. While the Return on Equity (ROE) stands at 8.41%, the Return on Capital Employed (ROCE) is slightly higher at 9.88%, indicating efficient capital allocation. The company's Operating Profit Margin (OPM) of 11.47% reflects decent operational efficiency, contributing to a Net Profit of 4 Cr. The healthy Promoter holding of 66.63% instills confidence, although the absence of FII and DII holdings raises questions about institutional interest. With a Price-to-Book Value (P/BV) ratio of 2.43x and Interest Coverage Ratio (ICR) of 2.31x, investors should closely monitor the company's cash conversion cycle (CCC) of 462 days and its leverage position, with reserves at 25 Cr. and borrowings at 42 Cr. In conclusion, while Shreeoswal Seeds & Chemicals Ltd shows promise, investors should keep a watchful eye on its liquidity management and debt levels

Competitors of Shreeoswal Seeds & Chemicals Ltd

All Competitor Stocks of Shreeoswal Seeds & Chemicals Ltd

Quarterly Result

Last Updated: August 20, 2025, 3:40 am

Below is a detailed analysis of the quarterly data for Shreeoswal Seeds & Chemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 97.95 Cr.. The value appears strong and on an upward trend. It has increased from 25.85 Cr. (Mar 2025) to 97.95 Cr., marking an increase of 72.10 Cr..
• For Expenses, as of Jun 2025, the value is 86.72 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 23.91 Cr. (Mar 2025) to 86.72 Cr., marking an increase of 62.81 Cr..
• For Operating Profit, as of Jun 2025, the value is 11.23 Cr.. The value appears strong and on an upward trend. It has increased from 1.94 Cr. (Mar 2025) to 11.23 Cr., marking an increase of 9.29 Cr..
• For OPM %, as of Jun 2025, the value is 11.47%. The value appears strong and on an upward trend. It has increased from 7.50% (Mar 2025) to 11.47%, marking an increase of 3.97%.
• For Other Income, as of Jun 2025, the value is 0.07 Cr.. The value appears to be declining and may need further review. It has decreased from 0.24 Cr. (Mar 2025) to 0.07 Cr., marking a decrease of 0.17 Cr..
• For Interest, as of Jun 2025, the value is 1.05 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.12 Cr. (Mar 2025) to 1.05 Cr., marking a decrease of 0.07 Cr..
• For Depreciation, as of Jun 2025, the value is 0.15 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.12 Cr. (Mar 2025) to 0.15 Cr., marking an increase of 0.03 Cr..
• For Profit before tax, as of Jun 2025, the value is 10.10 Cr.. The value appears strong and on an upward trend. It has increased from 0.94 Cr. (Mar 2025) to 10.10 Cr., marking an increase of 9.16 Cr..
• For Tax %, as of Jun 2025, the value is 27.92%. The value appears to be improving (decreasing) as expected. It has decreased from 40.43% (Mar 2025) to 27.92%, marking a decrease of 12.51%.
• For Net Profit, as of Jun 2025, the value is 7.28 Cr.. The value appears strong and on an upward trend. It has increased from 0.55 Cr. (Mar 2025) to 7.28 Cr., marking an increase of 6.73 Cr..
• For EPS in Rs, as of Jun 2025, the value is 0.80. The value appears strong and on an upward trend. It has increased from 0.06 (Mar 2025) to 0.80, marking an increase of 0.74.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 4:07 pm

Growth

Last Updated: September 5, 2025, 1:31 pm

Balance Sheet

Last Updated: June 16, 2025, 11:21 am

Below is a detailed analysis of the balance sheet data for Shreeoswal Seeds & Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 18.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 18.00 Cr..
• For Reserves, as of Mar 2025, the value is 25.00 Cr.. The value appears strong and on an upward trend. It has increased from 22.00 Cr. (Mar 2024) to 25.00 Cr., marking an increase of 3.00 Cr..
• For Borrowings, as of Mar 2025, the value is 42.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 64.00 Cr. (Mar 2024) to 42.00 Cr., marking a decrease of 22.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 19.00 Cr.. The value appears to be improving (decreasing). It has decreased from 20.00 Cr. (Mar 2024) to 19.00 Cr., marking a decrease of 1.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 105.00 Cr.. The value appears to be improving (decreasing). It has decreased from 124.00 Cr. (Mar 2024) to 105.00 Cr., marking a decrease of 19.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7.00 Cr. (Mar 2024) to 6.00 Cr., marking a decrease of 1.00 Cr..
• For CWIP, as of Mar 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 2.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 96.00 Cr.. The value appears to be declining and may need further review. It has decreased from 115.00 Cr. (Mar 2024) to 96.00 Cr., marking a decrease of 19.00 Cr..
• For Total Assets, as of Mar 2025, the value is 105.00 Cr.. The value appears to be declining and may need further review. It has decreased from 124.00 Cr. (Mar 2024) to 105.00 Cr., marking a decrease of 19.00 Cr..

However, the Borrowings (42.00 Cr.) are higher than the Reserves (25.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Shreeoswal Seeds & Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 0.39. This value is below the healthy minimum of 5. It has increased from -0.45 (Mar 24) to 0.39, marking an increase of 0.84.
• For Diluted EPS (Rs.), as of Mar 25, the value is 0.39. This value is below the healthy minimum of 5. It has increased from -0.45 (Mar 24) to 0.39, marking an increase of 0.84.
• For Cash EPS (Rs.), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 3. It has increased from -0.39 (Mar 24) to 0.44, marking an increase of 0.83.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 4.78. It has increased from 4.40 (Mar 24) to 4.78, marking an increase of 0.38.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 4.78. It has increased from 4.40 (Mar 24) to 4.78, marking an increase of 0.38.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 26.88. It has decreased from 29.41 (Mar 24) to 26.88, marking a decrease of 2.53.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 1.08. This value is below the healthy minimum of 2. It has increased from 0.12 (Mar 24) to 1.08, marking an increase of 0.96.
• For PBIT / Share (Rs.), as of Mar 25, the value is 1.02. This value is within the healthy range. It has increased from 0.06 (Mar 24) to 1.02, marking an increase of 0.96.
• For PBT / Share (Rs.), as of Mar 25, the value is 0.55. This value is within the healthy range. It has increased from -0.58 (Mar 24) to 0.55, marking an increase of 1.13.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 0.38. This value is below the healthy minimum of 2. It has increased from -0.45 (Mar 24) to 0.38, marking an increase of 0.83.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 0.38. This value is below the healthy minimum of 2. It has increased from -0.45 (Mar 24) to 0.38, marking an increase of 0.83.
• For PBDIT Margin (%), as of Mar 25, the value is 4.01. This value is below the healthy minimum of 10. It has increased from 0.41 (Mar 24) to 4.01, marking an increase of 3.60.
• For PBIT Margin (%), as of Mar 25, the value is 3.81. This value is below the healthy minimum of 10. It has increased from 0.22 (Mar 24) to 3.81, marking an increase of 3.59.
• For PBT Margin (%), as of Mar 25, the value is 2.07. This value is below the healthy minimum of 10. It has increased from -1.99 (Mar 24) to 2.07, marking an increase of 4.06.
• For Net Profit Margin (%), as of Mar 25, the value is 1.43. This value is below the healthy minimum of 5. It has increased from -1.54 (Mar 24) to 1.43, marking an increase of 2.97.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 1.43. This value is below the healthy minimum of 8. It has increased from -1.54 (Mar 24) to 1.43, marking an increase of 2.97.
• For Return on Networth / Equity (%), as of Mar 25, the value is 8.07. This value is below the healthy minimum of 15. It has increased from -10.34 (Mar 24) to 8.07, marking an increase of 18.41.
• For Return on Capital Employeed (%), as of Mar 25, the value is 20.39. This value is within the healthy range. It has increased from 1.44 (Mar 24) to 20.39, marking an increase of 18.95.
• For Return On Assets (%), as of Mar 25, the value is 3.35. This value is below the healthy minimum of 5. It has increased from -3.35 (Mar 24) to 3.35, marking an increase of 6.70.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 0.2. There is no change compared to the previous period (Mar 24) which recorded 0.00.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.95. This value is within the healthy range. It has decreased from 1.59 (Mar 24) to 0.95, marking a decrease of 0.64.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 2.15. It has increased from 2.13 (Mar 24) to 2.15, marking an increase of 0.02.
• For Current Ratio (X), as of Mar 25, the value is 1.56. This value is within the healthy range. It has increased from 1.35 (Mar 24) to 1.56, marking an increase of 0.21.
• For Quick Ratio (X), as of Mar 25, the value is 0.46. This value is below the healthy minimum of 1. It has increased from 0.35 (Mar 24) to 0.46, marking an increase of 0.11.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.49. This value is below the healthy minimum of 4. It has decreased from 2.71 (Mar 24) to 2.49, marking a decrease of 0.22.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 2.31. This value is below the healthy minimum of 3. It has increased from 0.18 (Mar 24) to 2.31, marking an increase of 2.13.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.83. This value is below the healthy minimum of 3. It has increased from 0.30 (Mar 24) to 1.83, marking an increase of 1.53.
• For Enterprise Value (Cr.), as of Mar 25, the value is 148.16. It has decreased from 327.05 (Mar 24) to 148.16, marking a decrease of 178.89.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.60. This value is below the healthy minimum of 1. It has decreased from 1.22 (Mar 24) to 0.60, marking a decrease of 0.62.
• For EV / EBITDA (X), as of Mar 25, the value is 15.01. This value exceeds the healthy maximum of 15. It has decreased from 293.97 (Mar 24) to 15.01, marking a decrease of 278.96.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.43. This value is below the healthy minimum of 1. It has decreased from 0.98 (Mar 24) to 0.43, marking a decrease of 0.55.
• For Price / BV (X), as of Mar 25, the value is 2.43. This value is within the healthy range. It has decreased from 6.62 (Mar 24) to 2.43, marking a decrease of 4.19.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.43. This value is below the healthy minimum of 1. It has decreased from 0.98 (Mar 24) to 0.43, marking a decrease of 0.55.
• For EarningsYield, as of Mar 25, the value is 0.03. This value is below the healthy minimum of 5. It has increased from -0.01 (Mar 24) to 0.03, marking an increase of 0.04.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness